ArticleScience translational medicine2011

Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT.

Alexander V Gasparian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.